Your browser doesn't support javascript.
loading
Germline genome-wide association studies in women receiving neoadjuvant chemotherapy with or without bevacizumab.
Ingle, James N; Kalari, Krishna R; Wickerham, Donald Lawrence; von Minckwitz, Gunter; Fasching, Peter A; Furukawa, Yoichi; Mushiroda, Taisei; Goetz, Matthew P; Barman, Poulami; Carlson, Erin E; Rastogi, Priya; Costantino, Joseph P; Cairns, Junmei; Paik, Soonmyung; Bear, Harry D; Kubo, Michiaki; Wang, Liewei; Wolmark, Norman; Weinshilboum, Richard M.
Afiliación
  • Ingle JN; Department of Oncology.
  • Kalari KR; Department of Health Sciences Research.
  • Wickerham DL; Department of Human Oncology, Allegheny Health Network Cancer Institute.
  • von Minckwitz G; National Surgical Adjuvant Breast and Bowel Project (NSABP) (NSABP legacy trials are now part of the NRG Oncology portfolio).
  • Fasching PA; Department of Gynecology and Obstetrics, University Hospital, Frankfurt.
  • Furukawa Y; Department of Gynecology and Obstetrics, Comprehensive Cancer Center Erlangen-EMN, University Hospital, Erlangen, Germany.
  • Mushiroda T; RIKEN Center for Integrative Medical Science, Yokohama, Japan.
  • Goetz MP; RIKEN Center for Integrative Medical Science, Yokohama, Japan.
  • Barman P; Department of Oncology.
  • Carlson EE; Department of Health Sciences Research.
  • Rastogi P; Department of Health Sciences Research.
  • Costantino JP; National Surgical Adjuvant Breast and Bowel Project (NSABP) (NSABP legacy trials are now part of the NRG Oncology portfolio).
  • Cairns J; Department of Medicine, University of Pittsburgh Cancer Institute.
  • Paik S; National Surgical Adjuvant Breast and Bowel Project (NSABP) (NSABP legacy trials are now part of the NRG Oncology portfolio).
  • Bear HD; Department of Biostatistics, University of Pittsburgh, Pittsburgh, Pennsylvania.
  • Kubo M; Department of Molecular Pharmacology and Experimental Therapeutics, Mayo Clinic, Rochester, Minnesota.
  • Wang L; National Surgical Adjuvant Breast and Bowel Project (NSABP) (NSABP legacy trials are now part of the NRG Oncology portfolio).
  • Wolmark N; Yonsei University College of Medicine, Seoul, South Korea.
  • Weinshilboum RM; National Surgical Adjuvant Breast and Bowel Project (NSABP) (NSABP legacy trials are now part of the NRG Oncology portfolio).
Pharmacogenet Genomics ; 28(6): 147-152, 2018 06.
Article en En | MEDLINE | ID: mdl-29768301
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neoplasias de la Mama / Terapia Neoadyuvante / Estudio de Asociación del Genoma Completo / Bevacizumab Tipo de estudio: Clinical_trials / Prognostic_studies / Risk_factors_studies Límite: Adult / Aged / Female / Humans / Middle aged Idioma: En Revista: Pharmacogenet Genomics Asunto de la revista: FARMACOLOGIA / GENETICA MEDICA Año: 2018 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neoplasias de la Mama / Terapia Neoadyuvante / Estudio de Asociación del Genoma Completo / Bevacizumab Tipo de estudio: Clinical_trials / Prognostic_studies / Risk_factors_studies Límite: Adult / Aged / Female / Humans / Middle aged Idioma: En Revista: Pharmacogenet Genomics Asunto de la revista: FARMACOLOGIA / GENETICA MEDICA Año: 2018 Tipo del documento: Article